News

The Manila Times2d
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)
Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...
Healio1d
Trastuzumab deruxtecan shows ‘encouraging real-world outcomes’ for metastatic breast cancer
Researchers who conducted a real-world analysis of trastuzumab deruxtecan found the drug to be effective in treating metastatic breast cancer, though survival outcomes did not reach clinical trial ...
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
FDA appoints George Tidmarsh as top drug regulator
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy
The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received ...
What's behind a spike in adverse event reports for Vyvanse, Australia's biggest ADHD drug?
Australia's pharmaceuticals watchdog is investigating a spike in adverse event reports for Vyvanse, the country's most ...
The BMJ4d
Malnutrition with use of GLP-1 agonists is an underestimated real world harm
Wraparound care for patients taking GLP-1 agonists must include assessment of nutritional status to identify the risk of malnutrition, writes Ellen Fallows Food insecurity is increasing, particularly ...